Katherine H. Goodrich, MD, MHS.

IRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a company that applies proven science and new technology to improve treatments for patients, starting with eyecare, has announced the appointment of Katherine H. Goodrich, MD, MHS, chief medical officer (CMO) of Humana Inc., to its board of directors. According to the announcement, Dr. Goodrich is a seasoned executive and practicing physician who has dedicated her career to championing innovative health care initiatives designed to improve health care access, equity and affordability.

“As a former CMO of Medicare and now CMO of a leading health insurance company, Kate has had an indelible impact on how government and private sector entities approach value-based care,” said Bobak Azamian, MD, PhD, CEO and chairman of Tarsus. “Her passion for ensuring optimal patient outcomes aligns squarely with our mission, and we are thrilled to apply her expertise to expanding the impact of Xdemvy and communicating the value proposition of future therapies.”

“Tarsus has created an entirely new category of disease, brought it to the forefront, and provided a novel solution to potentially millions of patients. That differentiated approach to patient impact is what drew me to Tarsus,” said Dr. Goodrich. “I am honored to have the opportunity to work with such a forward-thinking board and executive team as we continue building a leadership stake in eyecare and work to bring new medicines to patients in need.”

 
As chief medical officer for Humana, Dr. Goodrich provides executive clinical leadership for the insurance and CenterWell businesses of Humana, and oversees physician engagement, health care research, health equity and social impact initiatives, according to the announcement. Previously, she was the senior vice president for clinical analytics and trends within Humana’s Clinical Solutions organization, where she was accountable for producing the business analytics and rapid learning approach for clinical programs designed to improve outcomes at lower cost.

Prior to joining Humana, Dr. Goodrich was at the Centers for Medicare and Medicaid Services (CMS), where she was the director of the Center for Clinical Standards and Quality (CCSQ) and CMS’s chief medical officer.

For more than 25 years, Dr. Goodrich has served as a faculty member at the George Washington University Medical Center (GWUMC). She continues to practice clinical medicine as a hospitalist and professor of medicine at GWUMC. Dr. Goodrich currently serves on the boards of the National Quality Forum, the Institute for Accountable Care and the Delaware Valley ACO. She earned her MD from the Louisiana State University School of Medicine and her master’s in health services research from Yale University.